Found: 9
Select item for more details and to access through your institution.
Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex.
- Published in:
- Nature Cell Biology, 2004, v. 6, n. 5, p. 443, doi. 10.1038/ncb1123
- By:
- Publication type:
- Article
Discovery of MK-8970: An Acetal Carbonate Prodrug of Raltegravir with Enhanced Colonic Absorption.
- Published in:
- ChemMedChem, 2015, v. 10, n. 2, p. 245, doi. 10.1002/cmdc.201402393
- By:
- Publication type:
- Article
Cover Picture: Discovery of MK-8970: An Acetal Carbonate Prodrug of Raltegravir with Enhanced Colonic Absorption (ChemMedChem 2/2015).
- Published in:
- ChemMedChem, 2015, v. 10, n. 2, p. 213, doi. 10.1002/cmdc.201590000
- By:
- Publication type:
- Article
Use of a Bile Salt Export Pump Knockdown Rat Susceptibility Model to Interrogate Mechanism of Drug-Induced Liver Toxicity.
- Published in:
- Toxicological Sciences, 2019, v. 170, n. 1, p. 180, doi. 10.1093/toxsci/kfz079
- By:
- Publication type:
- Article
Antibiotic-Induced Elevations of Plasma Bile Acids in Rats Independent of Bsep Inhibition.
- Published in:
- Toxicological Sciences, 2017, v. 157, n. 1, p. 30, doi. 10.1093/toxsci/kfx015
- By:
- Publication type:
- Article
Transporters and Toxicity: Insights From the International Transporter Consortium Workshop 4.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 527, doi. 10.1002/cpt.2638
- By:
- Publication type:
- Article
Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 5, p. 916, doi. 10.1002/cpt.1222
- By:
- Publication type:
- Article
Design of Prodrugs to Enhance Colonic Absorption by Increasing Lipophilicity and Blocking Ionization.
- Published in:
- Pharmaceuticals (14248247), 2014, v. 7, n. 2, p. 207, doi. 10.3390/ph7020207
- By:
- Publication type:
- Article
Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 8, p. 1566, doi. 10.3390/v13081566
- By:
- Publication type:
- Article